Lucid Diagnostics Stock Market Value
| LUCD Stock | USD 1.36 0.02 1.45% |
| Symbol | Lucid |
Will Health Care Equipment & Supplies sector continue expanding? Could Lucid diversify its offerings? Factors like these will boost the valuation of Lucid Diagnostics. Expected growth trajectory for Lucid significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lucid Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.033 | Return On Assets | Return On Equity |
Understanding Lucid Diagnostics requires distinguishing between market price and book value, where the latter reflects Lucid's accounting equity. The concept of intrinsic value - what Lucid Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Lucid Diagnostics' price substantially above or below its fundamental value.
Understanding that Lucid Diagnostics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lucid Diagnostics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Lucid Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Lucid Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lucid Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lucid Diagnostics.
| 11/24/2025 |
| 02/22/2026 |
If you would invest 0.00 in Lucid Diagnostics on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Lucid Diagnostics or generate 0.0% return on investment in Lucid Diagnostics over 90 days. Lucid Diagnostics is related to or competes with Rapid Micro, Apyx Medical, Avita Medical, Opus Genetics, Sharps Technology, Anteris Technologies, and Seer. Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company More
Lucid Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lucid Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lucid Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.18 | |||
| Information Ratio | 0.0972 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 6.09 |
Lucid Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lucid Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lucid Diagnostics' standard deviation. In reality, there are many statistical measures that can use Lucid Diagnostics historical prices to predict the future Lucid Diagnostics' volatility.| Risk Adjusted Performance | 0.0993 | |||
| Jensen Alpha | 0.386 | |||
| Total Risk Alpha | 0.0872 | |||
| Sortino Ratio | 0.1081 | |||
| Treynor Ratio | 1.03 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lucid Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lucid Diagnostics February 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0993 | |||
| Market Risk Adjusted Performance | 1.04 | |||
| Mean Deviation | 2.69 | |||
| Semi Deviation | 2.66 | |||
| Downside Deviation | 3.18 | |||
| Coefficient Of Variation | 833.47 | |||
| Standard Deviation | 3.54 | |||
| Variance | 12.51 | |||
| Information Ratio | 0.0972 | |||
| Jensen Alpha | 0.386 | |||
| Total Risk Alpha | 0.0872 | |||
| Sortino Ratio | 0.1081 | |||
| Treynor Ratio | 1.03 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 6.09 | |||
| Downside Variance | 10.13 | |||
| Semi Variance | 7.09 | |||
| Expected Short fall | (3.38) | |||
| Skewness | 0.8144 | |||
| Kurtosis | 1.66 |
Lucid Diagnostics Backtested Returns
Lucid Diagnostics appears to be very risky, given 3 months investment horizon. Lucid Diagnostics has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Lucid Diagnostics, which you can use to evaluate the volatility of the firm. Please exercise Lucid Diagnostics' Risk Adjusted Performance of 0.0993, downside deviation of 3.18, and Mean Deviation of 2.69 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lucid Diagnostics holds a performance score of 10. The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Lucid Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Lucid Diagnostics is expected to be smaller as well. Please check Lucid Diagnostics' maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Lucid Diagnostics' current price movements will revert.
Auto-correlation | 0.45 |
Average predictability
Lucid Diagnostics has average predictability. Overlapping area represents the amount of predictability between Lucid Diagnostics time series from 24th of November 2025 to 8th of January 2026 and 8th of January 2026 to 22nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lucid Diagnostics price movement. The serial correlation of 0.45 indicates that just about 45.0% of current Lucid Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.45 | |
| Spearman Rank Test | 0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Lucid Diagnostics is a strong investment it is important to analyze Lucid Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lucid Diagnostics' future performance. For an informed investment choice regarding Lucid Stock, refer to the following important reports:Check out Lucid Diagnostics Correlation, Lucid Diagnostics Volatility and Lucid Diagnostics Performance module to complement your research on Lucid Diagnostics. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Lucid Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.